Narges Eskandari-Roozbahani

Dr. Narges Eskandari-Roozbahani

Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Science, Kermanshah Iran
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in New Microbes and New Infections
Verified
Journal Article
Open access
HSH. Sarvazad
H. Sarvazad
SCS.H. Cahngaripour
S.H. Cahngaripour
NENarges Eskandari-Roozbahani
Narges Eskandari-Roozbahani
BIB. Izadi
B. Izadi
We examined electrolyte imbalance and blood sugar levels in patients with COVID-19 who had no underlying disease. This cross-sectional study in a clinical center was performed in Kermanshah, west of Iran. All patients who had a record of magnesium (Mg2+), potassium (K+), sodium (Na+), and fasting blood sugar (FBS) tests in their clinical files at the time of admission to the hospital from April 21 to July 12, and didn't have a history of an underlying disease, were included in the study. Patients were divided into outpatient (as less severe COVID-19) and intensive care units (ICU) (as severe COVID-19). For statistical analysis of collected data, the SPSS software (version 16) was used. Among a total of 134 patients, 58 cases (24 ICU and 34 outpatients) were included in the study. The mean and median age was 56 and 62 years, respectively. From all included, 33 men (57%), 25 women (43%), 52 urban (89.7%), 6 rural (10.3%), 41 alive (70.7%), and 17 died (29.3%) were recorded. From all included patients, 49.1% hyperglycemia, 38% hyponatremia, 7.3% hypokalemia, and 32% hypomagnesemia were observed. Unlike the mean of age and the level of K+, there was a statistically significant difference between the outpatient and ICU groups in terms of Mg2+, Na+, and FBS (p < 0.05). Hyperglycemia and electrolyte imbalance in COVID-19 patients is feasible. Therefore, notice to measuring these cases and monitoring the patient can be effective in the treatment process and prevent the serious complications of the disease.

26 July 2021 in Reproductive Health
Verified
Journal Article
Open access
PDF file
NSNahid Sarahian
Nahid Sarahian
HSHosna Sarvazad
Hosna Sarvazad
ESElham Sajadi
Elham Sajadi
NRNasrin Rahnejat
Nasrin Rahnejat
NENarges Eskandari-Roozbahani
Narges Eskandari-Roozbahani
Background: The most common endocrine and metabolic disorders in premenopausal women is polycystic ovary syndrome (PCOS), characterized by hyperandrogenism, chronic anovulation, and/or ultrasound evidence of small ovarian cysts. Obesity and insulin resistance are also the main factors influencing the clinical manifestations of this syndrome. Alzheimer’s disease (AD) is the most typical progressive neurodegenerative disorder of the brain, and recent studies suggest a relationship between endocrinal dysregulation and neuronal loss during AD pathology. Aim: This study aimed to evaluate the common risk factors for Alzheimer’s and PCOS based on previous studies. Knowing the common risk factors and eliminating them may prevent neurodegenerative Alzheimer’s disease in the future. Method: In this narrative review, international databases, including Google Scholar, Scopus, PubMed, and the Web of Science, were searched to retrieve the relevant studies. The relevant studies’ summaries were categorized to discuss the possible pathways that may explain the association between Alzheimer’s and PCOS signs/symptoms and complications. Results: According to our research, the factors involved in Alzheimer’s and PCOS disorders may share some common risk factors. In patients with PCOS, increased LH to FSH ratio, decreased vitamin D, insulin resistance, and obesity are some of the most important factors that may increase the risk of Alzheimer’s disease.

15 October 2021 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
NSNahid Sarahian
Nahid Sarahian
MNMahsa Noroozzadeh
Mahsa Noroozzadeh
MNMarzieh Saei Ghare Naz
Marzieh Saei Ghare Naz
NENarges Eskandari-Roozbahani
Narges Eskandari-Roozbahani
FMFatemeh Mahboobifard
Fatemeh Mahboobifard
FTFahimeh Ramezani Tehrani
Fahimeh Ramezani Tehrani

23 February 2022 in Journal of International Medical Research
Verified
Journal Article
Open access
SCShahab Changaripour
Shahab Changaripour
HSHosna Sarvazad
Hosna Sarvazad
MBMaryam Barghi
Maryam Barghi
ESElham Sajadi
Elham Sajadi
MSMahdi Hashempour Sadeghian
Mahdi Hashempour Sadeghian
NENarges Eskandari-Roozbahani
Narges Eskandari-Roozbahani
Objective: To evaluate blood lipid profiles in patients with coronavirus disease 2019 (COVID-19), and to explore the association with disease severity. Methods: This case–control study included patients with COVID-19, referred to two medical centers in Kermanshah, Iran (between July 2020 and December 2020), and healthy controls. Lipid profiles were evaluated in patients who were grouped according to severe (intensive care unit [ICU]), or less severe (outpatient), forms of COVID-19, and in healthy controls, and were compared among the three groups. Results: A total of 132 participants were included, comprising ICU ( n = 49), outpatient ( n = 48) and control ( n = 35) groups. Mean cholesterol levels were lower in the patient groups than in controls; high-density lipoprotein cholesterol (HDL-C) levels were higher in the ICU group versus outpatients, and low-density lipoprotein cholesterol (LDL-C) levels were lower in the ICU group versus outpatients. The frequency of diabetes and hypertension was higher in the ICU group than in the outpatient group. Furthermore, LDL-C level was associated with disease severity (odds ratio 0.966, 95% confidence interval 0.944, 0.989). Conclusion: Lipid profiles differ between severe and less severe forms of COVID-19. LDL-C level may be a useful indicator of COVID-19 severity.

29 September 2022 in Journal of International Medical Research
Verified
Journal Article
Open access
EJEtrat Javadirad
Etrat Javadirad
NENarges Eskandari-Roozbahani
Narges Eskandari-Roozbahani
SSSepehr Sadafi
Sepehr Sadafi
Eosinophilic angiocentric fibrosis (EAF) is a rare chronic benign disorder of unknown etiology and is characterized by submucosal thickening and fibrosis in the upper respiratory tract. In this report, we describe a case of EAF in the nasal cavity of a woman who underwent elective surgery for division of adhesions and has had no recurrence during 2 years of postoperative follow-up. A review of the literature on the clinical manifestations of EAF, sites of lesions, management, and outcomes identified 48 articles that included 72 cases. A summary of these reports is presented, including our present case. The most common anatomic site involved was the nose (77.8%), the most common manifestation was nasal obstruction (66.7%), and the most common treatment modality was surgical resection (83.3%). After surgery, 36% of patients remained free of EAF. The most common pharmacologic agent used was a corticosteroid (38.9%).

10 May 2021 in Functional Foods in Health and Disease
Verified
Journal Article
Open access
PDF file
MBMaryam Barghi
Maryam Barghi
ARAmir Sadeghipoor Ranjbar
Amir Sadeghipoor Ranjbar
HMHoma Moazen
Homa Moazen
NENarges Eskandari-Roozbahani
Narges Eskandari-Roozbahani
Introduction: Diabetes mellitus is a metabolic disease that is a primary public health consideration. Low Vitamin D levels are linked to type 2 diabetes (T2DM), diminished insulin release, and enhanced insulin resistance in humans and animals. Vitamin D is also involved in the regulation of calcium and phosphorus homeostasis. Oxidative stress and antioxidant imbalances are important for the progression of diabetes as well. In this endeavor, the levels of vitamin D, calcium, phosphorus, and evaluation of the oxidant- antioxidant factors of malondialdehyde (MDA) and total antioxidant capacity (TAC) in healthy and diabetic people were compared.Methods: This descriptive-analytical study was conducted in 2020 in Shiraz, Fars province, Iran. The population included 40 T2DM patients (with HbA1c equivalent 6-8) without comorbidities, 20-60 years old for both genders, and 40 healthy individuals (female and male between 20-60 years old without comorbidities). The high-performance liquid chromatography (HPLC) method was adopted for measuring Vitamin D and for measuring other levels, the colorimetric method was used. Using SPSS 22, statistical analysis was performed. The Mann- Whitney U test for quantitative data was applied. P<0.05 was deemed significant.Results: There was a statistically significant difference between the two groups when it came to the means of vitamin D and MDA. In the diabetic group, vitamin D levels were lower (p=0.001) and MDA levels were higher (p<0.001). Comparing the level of calcium and phosphorus in diabetics and healthy people revealed no significant difference. This result was also true for the TAC test.Conclusions: According to our results, the mean of vitamin D in T2DM was significantly lower than healthy people and MDA in T2DM significantly increased compared to the control group, suggesting that increasing the activity of this enzyme in the development of secondary complications in diabetic patients is a predisposing factor.Keywords: Vitamin D, Diabetes mellitus, HPLC, Oxidative stress